中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2015年
16期
16-17,18
,共3页
黄健%王军%梁传兴%黄映梅
黃健%王軍%樑傳興%黃映梅
황건%왕군%량전흥%황영매
骶骨脊索瘤%原位微波消融灭活术
骶骨脊索瘤%原位微波消融滅活術
저골척색류%원위미파소융멸활술
Sacral vertebrae chordoma%Microwave ablation in situ inactivation method
目的:探讨手术切除结合原位微波消融灭活术在骶骨脊索瘤治疗中的临床效果。方法6例骶骨脊索瘤患者,采用手术切除结合原位微波消融灭活术治疗,平均随访27.4个月,对手术入路、术中出血的控制、局部肿瘤病灶的处理、骶神经根的保护及术后并发症等进行回顾性分析。结果本组S3及以下肿瘤4例, S2肿瘤2例,6例患者均未出现肺转移及死亡病例。结论手术切除是骶骨脊索瘤最主要的治疗方法,术中出血的控制及骶神经根的保护是手术的关键,化疗及放疗效果不确切,局部结合微波消融灭活取得了满意的临床效果,值得临床借鉴。
目的:探討手術切除結閤原位微波消融滅活術在骶骨脊索瘤治療中的臨床效果。方法6例骶骨脊索瘤患者,採用手術切除結閤原位微波消融滅活術治療,平均隨訪27.4箇月,對手術入路、術中齣血的控製、跼部腫瘤病竈的處理、骶神經根的保護及術後併髮癥等進行迴顧性分析。結果本組S3及以下腫瘤4例, S2腫瘤2例,6例患者均未齣現肺轉移及死亡病例。結論手術切除是骶骨脊索瘤最主要的治療方法,術中齣血的控製及骶神經根的保護是手術的關鍵,化療及放療效果不確切,跼部結閤微波消融滅活取得瞭滿意的臨床效果,值得臨床藉鑒。
목적:탐토수술절제결합원위미파소융멸활술재저골척색류치료중적림상효과。방법6례저골척색류환자,채용수술절제결합원위미파소융멸활술치료,평균수방27.4개월,대수술입로、술중출혈적공제、국부종류병조적처리、저신경근적보호급술후병발증등진행회고성분석。결과본조S3급이하종류4례, S2종류2례,6례환자균미출현폐전이급사망병례。결론수술절제시저골척색류최주요적치료방법,술중출혈적공제급저신경근적보호시수술적관건,화료급방료효과불학절,국부결합미파소융멸활취득료만의적림상효과,치득림상차감。
Objective To investigate the clinical effect of resection combined with microwave ablation in situ inactivation method in the treatment of sacral vertebrae chordoma.Methods There were 6 patients with sacral vertebrae chordoma treated by resection combined with microwave ablation in situ inactivation method, with the average follow-up as 27.4 months. Their surgical approach, intraoperative bleeding control, local tumor lesion treatment, sacral nerve root protection, and postoperative complications were all retrospectively analyzed. Results There were 4 cases with S3 and lower level of tumor, and the other 2 cases with S2 level of tumor. No pulmonary metastasis and death cases occurred in the 6 cases.Conclusion Resection is the main treatment method for sacral vertebrae chordoma. Intraoperative bleeding control and sacral nerve root protection are the keys to operation. Although chemotherapy and radiotherapy provide imprecise effect, local combination of resection and microwave ablation inactivation can provide satisfactory clinical effect. This method is worthy of clinical reference.